These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
371 related articles for article (PubMed ID: 25849605)
1. Radiological and pathological features associated with IDH1-R132H mutation status and early mortality in newly diagnosed anaplastic astrocytic tumours. Wasserman JK; Nicholas G; Yaworski R; Wasserman AM; Woulfe JM; Jansen GH; Chakraborty S; Nguyen TB PLoS One; 2015; 10(4):e0123890. PubMed ID: 25849605 [TBL] [Abstract][Full Text] [Related]
2. Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas. Hartmann C; Hentschel B; Wick W; Capper D; Felsberg J; Simon M; Westphal M; Schackert G; Meyermann R; Pietsch T; Reifenberger G; Weller M; Loeffler M; von Deimling A Acta Neuropathol; 2010 Dec; 120(6):707-18. PubMed ID: 21088844 [TBL] [Abstract][Full Text] [Related]
3. IDH1/2 gene hotspot mutations in central nervous system tumours: analysis of 922 Chinese patients. Chen N; Yu T; Gong J; Nie L; Chen X; Zhang M; Xu M; Tan J; Su Z; Zhong J; Zhou Q Pathology; 2016 Dec; 48(7):675-683. PubMed ID: 27780605 [TBL] [Abstract][Full Text] [Related]
4. Cerebrospinal fluid dissemination of high-grade gliomas following boron neutron capture therapy occurs more frequently in the small cell subtype of IDH1 Kondo N; Barth RF; Miyatake SI; Kawabata S; Suzuki M; Ono K; Lehman NL J Neurooncol; 2017 May; 133(1):107-118. PubMed ID: 28534152 [TBL] [Abstract][Full Text] [Related]
5. Phosphorylated Hsp27 is mutually exclusive with ATRX loss and the IDH1 Cai HQ; Wang PF; Zhang HP; Cheng ZJ; Li SW; He J; Zhang Y; Hao JJ; Wang MR; Yan CX; Wan JH J Clin Pathol; 2018 Aug; 71(8):702-707. PubMed ID: 29550762 [TBL] [Abstract][Full Text] [Related]
6. Diagnostic algorithm for pathological evaluation of gliomas in a resource-constrained setting. Jain S; Gupta P; Shankar KB; Singh R; Siraj F J Cancer Res Ther; 2023; 19(3):562-566. PubMed ID: 37470575 [TBL] [Abstract][Full Text] [Related]
7. Isocitrate dehydrogenase 1 R132H mutation is not detected in angiocentric glioma. Raghunathan A; Olar A; Vogel H; Parker JR; Coventry SC; Debski R; Albarracin CT; Aldape KD; Cahill DP; Powell SZ; Fuller GN Ann Diagn Pathol; 2012 Aug; 16(4):255-9. PubMed ID: 22445362 [TBL] [Abstract][Full Text] [Related]
8. Hsp27 and its expression pattern in diffusely infiltrating astrocytomas. Mäkelä KS; Haapasalo JA; Ilvesaro JM; Parkkila S; Paavonen T; Haapasalo HK Histol Histopathol; 2014 Sep; 29(9):1161-8. PubMed ID: 24599602 [TBL] [Abstract][Full Text] [Related]
9. KPNA2 predicts long term survival in patients with anaplastic oligoastrocytomas. Gousias K; Niehusmann P; Gielen G; Simon M; Boström J J Clin Neurosci; 2014 Oct; 21(10):1719-24. PubMed ID: 24929863 [TBL] [Abstract][Full Text] [Related]
10. Radiological features combined with IDH1 status for predicting the survival outcome of glioblastoma patients. Wang K; Wang Y; Fan X; Wang J; Li G; Ma J; Ma J; Jiang T; Dai J Neuro Oncol; 2016 Apr; 18(4):589-97. PubMed ID: 26409566 [TBL] [Abstract][Full Text] [Related]
11. Secondary Glioblastoma: Molecular and Clinical Factors That Affect Outcome After Malignant Progression of a Lower Grade Tumor. Gessler F; Zappi J; Konczalla J; Bernstock JD; Forster MT; Wagner M; Mittelbronn M; Seifert V; Senft C World Neurosurg; 2017 Jun; 102():49-55. PubMed ID: 28263929 [TBL] [Abstract][Full Text] [Related]
15. Loss of BCAT1 Expression is a Sensitive Marker for IDH-Mutant Diffuse Glioma. Chen YY; Ho HL; Lin SC; Hsu CY; Ho DM Neurosurgery; 2019 Sep; 85(3):335-342. PubMed ID: 30113684 [TBL] [Abstract][Full Text] [Related]
16. IDH1 mutant malignant astrocytomas are more amenable to surgical resection and have a survival benefit associated with maximal surgical resection. Beiko J; Suki D; Hess KR; Fox BD; Cheung V; Cabral M; Shonka N; Gilbert MR; Sawaya R; Prabhu SS; Weinberg J; Lang FF; Aldape KD; Sulman EP; Rao G; McCutcheon IE; Cahill DP Neuro Oncol; 2014 Jan; 16(1):81-91. PubMed ID: 24305719 [TBL] [Abstract][Full Text] [Related]
17. Biphasic IDH1 phenotype in a diffusely infiltrating glioma: implications for pathogenesis, treatment and prognosis. Odia Y; Varma H; Tsankova NM Clin Neuropathol; 2015; 34(5):282-7. PubMed ID: 25907263 [TBL] [Abstract][Full Text] [Related]